Therapeutic Action
Loop diuretic
PDF page 151
Drug reference
Loop diuretic
PDF page 151
Oedema associated with renal, hepatic or congestive heart failure
PDF page 151
Do not administer to patients with dehydration, severe hypokalaemia and hyponatraemia. May cause: dehydration, hypotension, hypokalaemia, hyponatraemia, hyperuricemia; renal impairment, deafness, photosensitivity. Avoid or monitor combination with NSAIDs, ACE inhibitors (risk of renal impairment); ototoxic drugs (e.g. aminoglycosides, quinine); lithium (increased plasma concentrations of lithium). Monitor combination with: drugs that provoke hypotension (e.g. haloperidol, amitriptyline) and antihypertensive drugs (risk of hypotension); potassium-depleting drugs (e.g. corticosteriods, laxatives, amphotericin B), sodium-depleting drugs (e.g. SSRI, carbamazepine); oral antidiabetics and insulin (risk of hyperglycaemia). Pregnancy: administer only if clearly needed Breast-feeding: CONTRA-INDICATED (excreted in milk and reduces milk production)
PDF pages 151, 152
20 mg and 40 mg tablets
PDF page 151
Adult: start with 20 mg once daily. Increase, if necessary, according to clinical response up to 80 mg once daily or 2 times daily (max. 160 mg daily). Once oedema decrease, reduce to 20 to 40 mg once daily.
PDF page 151
According to clinical response
PDF page 151
Preferably take in the morning. A potassium-rich diet (dates, bananas, mangos, oranges, tomatoes, etc.) is recommended during treatment. If potassium level is < 3.5 mmol/litre, administer a sustained-release potassium supplement. Diuretics are not indicated in the treatment of nutritional oedema or oedema associated with pre- eclampsia.
PDF page 152
- Below 25 °C
PDF page 152
start with 20 mg once daily. Increase, if necessary, according to clinical response up to 80 mg once daily or 2 times daily (max. 160 mg daily). Once oedema decrease, reduce to 20 to 40 mg once daily.
PDF page 151